Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06166277 · ClinicalTrials.gov registry record
Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry
A clinical trial of Vasovagal Syncope and AV Block-2Nd Degree-Type 1, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06166277: Recruiting study of Vasovagal Syncope and AV Block-2Nd Degree-Type 1, sponsored by Rush University Medical Center.
NCT06166277 is a study of Vasovagal Syncope and AV Block-2Nd Degree-Type 1 that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06166277, a study of Vasovagal Syncope and AV Block-2Nd Degree-Type 1, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacemaker implantation.
Primary Outcome
Recurrent syncope
Conditions Studied
Interventions
- PROCEDURE Ablation procedure
Study Locations (1)
Illinois
- Rush University Medical Centert - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2027-04-30 |
What NCT06166277 shows while recruiting
NCT06166277 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Vasovagal Syncope appearing as the primary indexed condition, and to 1 intervention - of which Ablation procedure is the first listed.
NCT06166277 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06166277 about?
NCT06166277 is a clinical study titled "Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry". The CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacemaker implantation.
What is the current status of trial NCT06166277?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2024-08-01. Estimated completion is 2027-04-30.
What conditions does trial NCT06166277 study?
This clinical trial studies the following conditions: Vasovagal Syncope, AV Block-2Nd Degree-Type 1, Sinus Pause.
What interventions are being tested in trial NCT06166277?
The interventions under investigation include: Ablation procedure (PROCEDURE).
Who is sponsoring clinical trial NCT06166277?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06166277 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasovagal Syncope
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI